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Abstract
Background: Atopic dermatitis (AD) is often the prelude to allergic diseases. The aim of this study was 1) to evaluate if 
an integrated management regime could bring about a change in the evolution of the disease in comparison to the 
results of a previous study; 2) to determine whether the refinement of allergic investigations allowed to identify more 
promptly the risk factors of evolution into respiratory allergic diseases.
Methods: The study included 176 children affected by AD and previously evaluated between 1993 and 2002 at the 
age of 9-16 months, who underwent a telephonic interview by means of a semi-structured, pre-formed questionnaire 
after a mean follow-up time of 8 years. According to the SCORAD, at first evaluation children had mild AD in 23% of 
cases, moderate in 62%, severe in 15%.
Results: AD disappeared in 92 cases (52%), asthma appeared in 30 (17%) and rhinoconjunctivitis in 48 (27%). The 
factors significantly related to the appearance of asthma were: sensitization to food allergens with sIgE > 2 KU/L (cow's 
milk and hen's egg; P < 0.05); to inhalant allergens with sIgE > 0.35 KU/L (P < 0.05). Logistic regression analysis showed 
that inhalant sensitization was positively related to the occurrence of asthma (OR = 4.219). While AD showed similar 
rates of disappearance to those of our previous study, the incidence of asthma was reduced, at the same follow-up 
time, from 29% to 15% (P = 0.002), and the incidence of rhinoconjunctivitis from 35% to 24% (P = 0.02).
Conclusion: Comparing the results with those of the previous study, integrated management of AD does not seem to 
influence its natural course. Nevertheless, the decrease in the percentage of children evolving towards respiratory 
allergic disease stresses the importance of early diagnosis and improvement management carried out by specialist 
centers. The presence of allergic sensitization at one year of age might predict the development of respiratory allergy.
Atopic dermatitis (AD) is the most frequent chronic skin
disease of childhood, with onset mainly in the first years
of life. The prevalence of AD has doubled or tripled in
industrialized countries over the past three decades: 15 to
30% of children and 2 to 10% of adults are affected [1]. In
70-80% of patients AD is associated with increased total
serum IgE levels and food/inhalant specific (s) IgE levels,
whereas in 20-30% there is no such sensitization [2].
In many cases, AD disappears or improves during
childhood. However, in some cases the disease may per-
sist into maturity and is associated with the development
of asthma and/or allergic rhinitis. The risk of developing
asthma in children with AD is highly variable: according
to some authors the prevalence is 25% while others sug-
gest higher values up to 80% [3-6]. This difference may be
due to the use of different clinical and laboratory meth-
ods.
In a previous study [3] our team tried to assess the nat-
ural course of AD, as well as factors that affect its disap-
pearance or persistence and the possible emergence of
other allergic respiratory diseases. Children included in
this study were aged between 6 and 36 months when they
had their first visit between 1981 and 1989, involving the
performance of allergometric tests and an assessment of
the clinical picture and family history for atopy. After a
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Page 2 of 12follow-up of about 10 years, AD had disappeared com-
pletely in 124 cases (60.5%). Seventy children (34.1%) had
developed asthma and 118 (57.6%) rhinoconjunctivitis
(RC).
The main aim of this study was to determine whether a
integrated clinical management had brought about a
change in the evolution of the AD in comparison with the
results of the previous study [3] carried out by our team
in the preceding decade.
Furthermore, we wished to see if the refinement of clin-
ical investigations (publication by the European Task
Force of SCORAD index [7], 1993) and laboratory tests
(determination of sIgE with quantitative method Immu-
noCAP™, 1989) allowed us to identify more promptly the
risk factors in children with AD and predict the evolution
of AD into respiratory allergic diseases.
Methods
A. Study design
A.1. Phases of the study
This study consisted of two phases:
1) a retrospective analysis of children affected by AD 
at the age of 9-16 months;
2) telephone contact of the selected patients in order 
to evaluate the follow-up.
Only patients who were first evaluated, as infants, in
our Pediatric Allergology Outpatients clinic were
included, and the same team of physicians performed the
follow-up telephone interviews.
It is interesting to note that, although our center may be
considered a tertiary one, it is the practice of local
national health pediatricians to send all patients with sus-
pected AD, even with mild severity, to a specialist to per-
form allergometric assessment, so that the severity
grading of this population has a wide variability.
A.2. Inclusion criteria
a) diagnosis of AD at an age of 9 to 16 months made at 
our Pediatric Allergology Outpatients Clinic, with a 
first clinical examination between 1993 and 2002;
b) availability of a detailed family and personal his-
tory;
c) performance of allergometric tests (skin prick tests 
(SPTs) and sIgE serum level for food and inhalant 
allergens);
d) telephone availability;
e) informed consent by the parents.
A.3. Exclusion criteria
1) patients who did not fulfill the inclusion criteria;
2) patients whose parents did not give their consent 
for inclusion;
3) patients who had other serious or invalidating asso-
ciated pathologies.
B. Clinical assessment and AD management
B.1. Clinical assessment
At the time of the first observation, the diagnosis of AD
was made by the physicians on the basis of the criteria of
Hanifin and Rajka [8]; parents or siblings were regarded
as atopic if they reported a diagnosis of AD, RC or
asthma.
At the first visit, the evaluation of the severity of AD
was assessed by the SCORAD index [7].
SCORAD index < 25 shows a mild AD, 25-50 a moder-
ate form, > 50 a severe form.
The new SCORAD index was not adopted to avoid
affecting comparison with the previous study [3].
B.2. Management of AD
Since the '90s there has been an improvement in the
global approach to children with AD both from an aller-
gological and dermatological point of view. In particular
an environmental prophylaxis has always has been rec-
ommended to all subjects positive to any allergens, along
with a strict integrated management to obtain a very
stringent control of flares with repeated control when
SCORAD index is moderate or severe.
B.2.1. Environmental Prevention
Mite sensitization is often present in patients with atopic
eczema, and may evoke or worsen skin reactions [9]. For
children with sensitization to inhalant allergens, environ-
mental prophylaxis was recommended in order to reduce
the level of mites allergens in the home through bed
encasing with special fabric textiles, the use of a high-fil-
tration vacuum cleaning and the avoidance of objects
containing dust in patient room.
B.2.2. Integrated management
The management of AD treatment has been widely dis-
cussed in literature [10] and in our previous work [11]
and a step-based approach to the disease has been pro-
posed. Dry skin should be only treated with emollients
and avoidance of trigger factors. For mild to moderate
and moderate to severe forms of AD, topical corticoster-
oids of increasing potency and/or topical calcineurin
inhibitors are suggested. Systemic therapy should only be
considered in case of severe, recalcitrant AD. When
symptoms flare repeatedly, physicians may consider sev-
eral systemic therapies, such as aggressive short-course
systemic corticosteroids, immunosuppressants, biologi-
cals, antimicrobials, anthistamines and leukotriene inhib-
itors.
B.3. Allergometric assessment
Allergometric assessment was performed at baseline
(between 1993 and 2002) using SPT and determination of
total and sIgE.
The determination of total serum IgE level was per-
formed by PRIST (Pharmacia, Uppsala, Sweden); the
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comparison with normal children of the same age group
[12].
The determination of sIgE was performed by Immuno-
CAP™ (Pharmacia, Sweden) and was measured in all
patients for the following allergens: cow's milk, hen's egg,
soybean, wheat, peanut, nut, codfish, apple, grass pollen,
house dust mite (D. pteronyssinus, D. farinae), cat dander,
dog dander. We considered as positive a sensitization to
the allergen with a serum IgE level greater than 0.35 KU/
L.
All the sera were tested for total and sIgE levels in the
central laboratory of our hospital.
The SPT was made in all patients for the following
allergens: cow's milk, hen's egg, soybean, wheat, peanut,
nut, codfish, apple, grass pollen, house dust mite (D. pter-
onyssinus, D farinae), cat dander, dog dander, and Alter-
naria. Positivity was assessed by comparing the wheal of
the allergens with that of the histamine, as suggested by
the Consensus Conference of the Group of Allergology
and Pediatric Immunology [13].
C. Telephone interview
C.1. Contact with the families of children for the purposes of 
administering a phone questionnaire
Of the 177 selected children, 176 replied to the telephone
questions (Fig.1). All the families were informed about
the aim of the study and were generally very willing to
supply the necessary information.
Parents of participants responded by telephon slightly
modified versions of the International Study of Asthma
and Allergies in Childhood (ISAAC) questionnaires [14].
Only the diagnoses of asthma and RC made by the gen-
eral practitionnaire or by a pediatric allergologist/pneu-
mologist on the basis of objective data were considered
valid.
C.2. Availability for a check-up
During the telephone interview the possibility of a clini-
cal allergologic evaluation was offered; this was wel-
comed by many parents (103 children agreed to follow up
visit).
D. Data collection and analysis
D.1. Completion of a database with the following information
- sex;
- age at first examination;
- assessment determination of the severity of the dis-
ease through a clinical score [7];
- SPT for food and inhalant allergens;
- total and sIgE serum level at first observation.
D.2. Statistical analysis
Elaboration of the data was made by an expert in statis-
tics.
Statistical analysis was performed using software (SPSS
15 for Windows, SPSS Inc, Chicago, Ill). The evolution of
AD was related to the following factors: sex, severity of
the disease at first observation, family or personal history
of first-degree atopy, sensitization to food and inhalant
allergens (assessed by SPT and sIgE serum level), total IgE
level, persistence and duration of AD, and appearance
and age at onset of asthma and RC.
The presence or absence of the above-mentioned fac-
tors in patients with different severity scores of AD was
evaluated by contingency table, whereas Fisher's exact
test was used to test AD evolution for all the other men-
tioned variables that were dichotomous.
The duration of AD or onset age of RC and asthma
were compared by Fisher's analysis of variance in the dif-
ferent severity classes of AD (with Scheffe's post hoc test
if necessary), and by unpaired Student t test for all dichot-
omic variables. The risk of incomplete recovery of RC or
asthma onset was evaluated by corrected odds ratio (OR)
in models of logistic regression backward stepwise (likeli-
hood) method. Type I error was accepted at P less than
0.05.
E. Ethics
This study was only observational and did not interfere
with the clinical management of the patients, so it was
not submitted to the ethical committee for approval.
However, both the parents and the patients were
informed that the questionnaire was proposed in an
experimental manner; they were given the questionnaire
only after obtaining an informed consent.
Results
A total of 177 children fulfilling the above-mentioned cri-
teria of inclusion were contacted (Fig.1). The interview
questionnaire was completed for 176 children (Fig.1.) (98
boys, 56%, and 78 girls, 44%) (99.4%). The mean follow-
up of these patients was 91.3 ± 24.2 months (range 6-12
years).
The mean age of children at first observation was 11.7
months. At follow-up the mean age was 102.8 months.
Baseline data
Familial atopy
The evaluation of the first-degree familial atopy was pos-
sible only for 175 children because one child had been
adopted. In 58 patients (33%) the father was atopic, in 62
(35%) the mother and in 27 (15%) one or more brothers
or sisters.
Severity of AD
At first examination 40 of the 176 children (23%) had
mild AD (SCORAD index < 25), 110 (62%) moderate AD
(SCORAD index between 25 and 50 ), 26 (15%) severe
AD (SCORAD index > 50).
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Total IgE serum level was increased in 89 cases (51%) out
of the 174 (the IgE value of two children was not avail-
able) without any significant difference for sex.
The group of 85 children with normal IgE had a posi-
tive family history for atopy in 51 cases (60%).
The group with increased IgE had a positive family his-
tory for atopy in 57 cases out of 88 (65%).
The severity of AD was related to the values of the total
IgE serum level at the first examination, with no statisti-
cal significance, even though in the severe forms of AD
increased IgE levels were present in 17 cases out of 26
(65%).
SPT
One hundred patients out of 176 (57%), showed a sensiti-
zation to the SPT for at least one of the tested foods and/
or inhalants.
Positivity for SPT did not show any significant differ-
ence between the group of children with normal IgE
(54%) and that with increased IgE (58%).
Ninety-seven children were positive for food allergens
and 13 positive for inhalant allergens; of these, 3 children
were positive only for inhalants.
Serum sIgE
One hundred and three out of 176 patients (58.5%) had
elevated levels of sIgE for at least one allergen at first
observation.
The positive subjects were subsequently divided into
two groups: the first (44 cases) contained children with
sIgE level between 0.35 KU/L and 2 KU/L, the second (59
cases), subjects with a value > 2 KU/L. This cut-off value
was decided upon the work by Nickel and colleagues [12].
Data noted at follow-up
Outcome and evolution of AD
After the mean seven and a half year follow-up AD was
still present in 84 children (48%) out of 176, in 27 cases
(15%) with a persistent course, in 57 cases (32%) intermit-
tent, while in 92 cases (52%) AD had disappeared.
Of the children still suffering from AD, 37 out of 84
(44%) had a single location, primarily on the limbs, while
15 out of 84 (18%) had multiple locations.
The mean age of disappearance of the AD was 3.25
years. The mean age of disappearance was slightly higher
in severe AD (3.8 ± 1.0 years) than in the moderate (3.4 ±
0.4 years) or mild (2.8 ± 0.6 years) forms, but no statisti-
Figure 1 Study population flow chart.
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coud be seen in children with hen's egg sensitization: a
longer period was required in severe AD (3.7 ± 1.5 years)
than in moderate (3.1 ± 0.6 years) or mild (2.4 ± 0.6 years)
forms but also in this case the difference was not signifi-
cant.
Onset of respiratory allergic diseases
Respiratory allergic diseases appeared in 66 cases out of
176 (37.5%).
Of the 66 cases, 36 patients out of 176 (20.5%) devel-
oped only RC, 18 out of 176 (10%) developed only asthma
and 12 children out of 176 (7%) developed both RC and
asthma.
1) Allergic Rhinoconjunctivitis
The mean age of appearance of RC was 4.83 years.
In the 48 patients affected, the RC, both alone and in
association with asthma, had a seasonal course in 41
cases (85.5%), whereas in 7 cases (15%) it was perennial.
2) Asthma
The mean age of appearance of asthma was 3.33 years.
Out of 66 cases with respiratory allergic diseases, 30
(17%) had asthma, which in 18 cases was isolated and in
12 associated with RC.
All of the participants suffering from asthma had
undergone permanent or transitory therapy during the
last year: inhalant steroids in 25 cases (83%), short acting
beta2 agonists in 14 cases (47%), long acting in 8 cases
(27%) and antileukotrienes in 7 cases (23%).
In 26 cases out of 30 (87%) the asthma was under con-
trol (on the basis of the replies to the telephone question-
naire); in 4 cases the disease was only partially under
control.
Seventeen out of the 18 patients with isolated asthma
had their IgE serum level evaluated at first observation: 7
had normal IgE and 10 had increased IgE.
The total IgE serum level at first observation was signif-
icantly correlated with the appearance of the asthma,
both isolated and in association with RC (P < 0.05). In fact
the children with elevated levels of total IgE serum level
at baseline showed a relative risk of developing asthma
that is two times higher than those with normal levels.
Besides, the children with elevated levels of total IgE
serum level at baseline showed a relative risk of develop-
ing asthma in association with RC that is four times
greater in comparison to those with normal levels.
In the 30 patients with asthma, both isolated and asso-
ciated with RC, these disorders were correlated with sea-
sonal allergens in 22 cases (73%), and with perennial
allergens in 8 cases (27%).
Of the 30 children suffering from asthma, 20 presented
intermittent forms and 11 of these (55%) had increased
IgE; 6 cases had a mild persistent asthma with increased
IgE. The severe persistent asthma was present in 2 cases
(one with IgE serum level increased at baseline).
Comment at follow-up
During the follow-up AD had disappeared in 92 children
(52%) but if we also include the absence of respiratory
complications only 54 children (30.7%) showed no symp-
toms.
RC had appeared in 48 children (27%), asthma in 30
(17%) (Fig.2).
In the following figure (3) and table 1, table 2 and table
3) the different variables are considered in relation to the
evolution of AD.
A logistic regression backward stepwise (likelihood
ratio) method was performed for evaluation of AD persis-
tence, RC and asthma onset. The most suited models are
expressed in Table 4. The children that developed RC
(OR = 2.616), or were positive to at least one inhalant
(with sIgE > 0.35 KU/L at first observation) (OR = 4.219)
showed a greater risk of developing asthma.
Discussion
Regarding the clinical course of AD, the percentages of
persistence are extremely variable in the literature, rang-
ing from 8-13% to 60-70% [15-18]. Percentages of healing
with age in the literature are also variable. Some [19] state
50-70% healing by the age of 10 years, others [20] 43.2%
by the age of 3 and some [20,21] refer about a general
improvement in AD severity by the fith-seventh year of
life, with estimates of only 16% of persistence of AD after
adolescence [22].
The discrepancy between these data can be partly
explained by the fact that the methods used for diagnosis
(the criteria of Hanifin and Rajka [8] since the eighties)
and for the evaluation of severity of AD (SCORAD index
[7] introduced since 1993) were different in the various
series of cases. For these reasons we selected children
born in or after 1993, when we started applying the afore-
mentioned criteria. In the 8 year follow-up of the present
study, 50% of the children still had AD. Our data suggest
that, among all the various parameters, the greatest influ-
ence on the persistence of AD is the severity of the dis-
ease estimated through the SCORAD index [7] at the
moment of the first observation (Pearson χ2 = 4.846; P <
0.05) (Fig.3).
In our study, the mean age of disappearance is slightly
higher in severe AD (3.8 ± 1.0 years) than in the moderate
(3.4 ± 0.4 years) or mild (2.8 ± 0.6 years) forms, but no
statistically significant difference was found. The same
trend can be seen in children with hen's egg sensitization:
a longer period is required in severe AD (3.7 ± 1.5 years)
than in moderate (3.1 ± 0.6 years) or mild (2.4 ± 0.6 years)
forms but also in this case there is no significant differ-
ence.
In a previous work [3], our team tried to assess the nat-
ural course of AD, as well as factors that affect the disap-
pearance or persistence and the possible emergence of
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this study were aged between 6 and 36 months at the time
of their first visit (between 1981 and 1989) and had car-
ried out allergometric tests and an assessment of the clin-
ical picture and family history for atopy. Concerning AD,
the clinical characteristics of that population were similar
to those of the population of the present study: more
patients had mild AD (33% vs 23% in the present study)
and less had moderate AD (48% vs 62%), but the fre-
quency of severe AD was more or less the same (19% vs
15%). The population of the previous study had a lower
prevalence of sensitization to food allergens (37% vs 58%)
and a higher prevalence of sensitization to inhalant aller-
gens (26% vs 20%), and this might be explained by the age
at first evaluation, which was higher (6 to 36 months,
compared to 9 to 16 months of the present study). After a
follow-up of about 10 years, we reported that AD per-
sisted in 39.5% of cases and the mean age of disappear-
ance was 5.6 years.
Many data point towards a strong correlation between
AD in early infancy and the subsequent appearance of
asthma [23]. Children with AD present an increased fre-
quency of RC and asthma, with percentages varying from
25% to 80% [3-6]. Therefore, identifying subjects at risk of
complications in pediatric age could help prevent its
onset.
In the present study the percentages of appearance of
respiratory allergies is lower; in fact only 37.5% of chil-
dren with AD developed respiratory pathologies, RC in
27% of cases and asthma alone in 17%. This difference
can be explained partly by our lower degree of severity of
AD, and partly by non homogeneous diagnostic criteria.
In fact in several of the studies previously quoted the
diagnosis of AD was made using criteria not standardized
and not comparable until the eighties when the criteria of
Hanifin and Rajka [8] were published, criteria also
adopted in this study. This could have resulted in some
differences in the clinical evaluation. The incidence of
asthma in our case study is not high, perhaps partly
explainable by the fact that we considered as asthmatics
only the patients with a medical diagnosis of asthma,
excluding the episodes of "wheezing" in the first years of
life.
In the aforementioned previous study by our group [3],
involving children that had been first evaluated between
1981 and 1989, with similar characteristics, 57.6% of
patients developed RC and 34.1% asthma. Furthermore,
in our two studies the onset of these pathologies in the
majority of cases occurred before puberty (Fig.2). The
curve of appearance of asthma (Fig.2) reveals that at 8
years of age (mean age of our follow-up) the presence of
asthma in our previous study [3] was already around 29%,
while in the present study it is about 15% (Pearson χ2 =
9.928 and P = 0.002) (Fig.4); a reduction in the appear-
ance of asthma was therefore noted. Also the percentage
of RC had fallen from 35% to 24% (Pearson χ2 = 5.200 and
Figure 2 Curves related to the persistence of AD and to the appearance of RC, asthma, in the 176 children participating in the study.
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Table 1: Persistence of AD and appearance of RC and/or asthma in relation to food sensitization and inhalant sensitization 
assessed through sIgE (levels of IgE > 0.35 KU/L, between 0.35 and 2 KU/L and > 2 KU/L), and through SPT at first 
observation.
Variables Category N AD persistence RC appearance Asthma 
appearance
Food sensitization Absent 73 30 21 9
(specific IgE > 0.35 KU/L) 41%(29.8-52.4) 29%(18.4-39.2) 12%(4.8-19.9)
Present 103 54 27 21
52%(42.8-62.1) 26%(17.7-34.7) 20%(12.6-38.2)
Food sensitization Absent 130 57 39 24
(specific IgE 0.35-2 KU/L) 44%(35,3-52,4) 30%(22,1-37,9) 18%(11,8-25,1)
Present 46 27 9 6
59%(44,5-72,9) 20%(8,1-31,0) 13%(3,3-22,8)
Food sensitization Absent 119 57 30 15
(specific IgE > 2 KU/L) 48%(38.9-56.9) 25%(17.4-33.0) 13%(6.6-18.6)$
Present 57 27 18 15
47%(34.4-60.3) 32%(18.5-43.6) 26%(14.9-37.7)$
Food sensitization Absent 79 33 22 6
(PRICK) 41.8%(30.9-52.6) 27.8%(18.0-37.7) 7.6%(1.8-13.4)£
Present 97 51 26 24
52.6%(42.6-62.5) 26.8%(18.0-35.6) 24.7%(16.2-33.3)£
Inhalant sensitization Absent 140 62 37 19
(specific IgE > 0.35 KU/L) 44%(36,1-52,5) 26%(19,1-33,7) 14%(7,9-19,9)$
Present 36 22 11 11
61%(45,2-77,0) 31%(15,5-45,6) 31%(15,5-45,6)$
Inhalant sensitization Absent 163 79 41 27
(PRICK) 48.5%(40.8-56.1) 25.2%(18.5-31.8)$ 16.6%(10.9-22.3)
Present 13 5 7 3
38.5%(12.0-64.9) 53.8%(26.7-80.9)$ 23.1%(0.2-46.0)
Confidence intervals 95% for each item.
Atopic Dermatitis (AD), Rhinoconjunctivitis (RC), Immunoglobulin E (IgE).
$ Fisher's exact test; P < 0.05
£ Fisher's exact test; P < 0.005
Ricci et al. Clinical and Molecular Allergy 2010, 8:8
http://www.clinicalmolecularallergy.com/content/8/1/8
Page 8 of 12P = 0.023) (Fig.4). This better result could be related to an
improvement in the clinical management of AD. How-
ever, only follow-up will tell whether this trend is con-
firmed or asthma appearance is only postponed.
Van Der Hulst et al. [24] recently made a systematic
review to analyze the risk for a child that has had AD in
the first 4 years of life of developing asthma later in child-
hood. The review showed that after a varying period of
follow-up, the prevalence of asthma varied from 33.7% to
52.5% in inpatients and outpatients respectively, and from
14.2% to 45.5% in the mixed group.
In the work of Oshshima et al. [25], the persistence of
AD is strongly correlated with the onset of asthma.
Gustaffson et al. [26], in an assessment of 92 children
(aged 4-35 months) with AD after an 8 year follow-up,
show that 70% of patients with a severe form developed
asthma, compared to only 30% of children with a mild
form.
Also in our previous study [3] we observed that a high
SCORAD index at the first observation is associated with
a greater probability of appearance of asthma (Pearson
χ2= 14.225 and P < 0.007). On the other hand, the results
of the present study do not show any statistical signifi-
cance, even though it is possible to note a tendency point-
ing to a relationship between AD and asthma; 15% of
children with the light form developed asthma, compared
to 15.5% of those with moderate form and 26.9% of those
with the severe form. It is possible once again that these
statistics are influenced by the fact that there were few
children suffering from severe dermatitis and a more lim-
ited cohort.
In a study by Schafer et al. [27] involving 2201 children
aged between 5 and 14 years, the severity of AD was
again correlated to a greater probability of developing RC.
Parental atopy is a well documented risk factor for the
evolution of AD into allergic respiratory disease [25,28].
Table 2: Persistence of AD and appearance of RC and/or asthma in relation to cow's milk sensitization assessed through 
sIgE (levels of IgE > 0.35 KU/L, between 0.35 and 2 KU/L and > 2 KU/L), and through SPT at first observation.
Variables Category N AD persistence RC appearance Asthma 
appearance
Milk sensitization Absent 102 46 28 13
(specific IgE > 0.35 KU/L) 45,1%(35,4-54,8) 27,5%(18,8-36,1) 12,7%(6,3-19,2)
Present 74 38 20 17
51,4%(40,0-62,7) 27,0%(16,9-37,1) 23,0%(13,4-32,6)
Milk sensitization Absent 137 62 38 24
(specific IgE 0.35-2 KU/L) 45%(36.9-53.6) 28%(20.2-35.2) 18%(11.2-23.9)
Present 39 22 10 6
56%(40.8-72.0) 26%(11.9-39.3) 15%(4.1-26.7)
Milk sensitization Absent 141 68 38 19
(specific IgE > 2 KU/L) 48%(40.0-56.5) 27%(19.6-34.3) 13%(7.8-19.1)$
Present 35 16 10 11
46%(29.2-62.2) 29%(13.6-43.5) 31%(16.0-46.8)$
Milk sensitization Absent 128 56 35 16
(PRICK) 43.8%(35.2-52.3) 27.3%(19.6-35.1) 12.5%(6.8-18.2)&
Present 48 28 13 14
58.3%(44.4-72.3) 27.1%(14.5-39.7) 29.2%(16.3-42.0)&
Confidence intervals 95% for each item.
Atopic Dermatitis (AD), Rhinoconjunctivitis (RC), Immunoglobulin E (IgE).
$ Fisher's exact test; P < 0.05
& Fisher's exact test; P < 0.01
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Page 9 of 12Our results confirm this association, since 21.8% (Fisher's
exact test; P < 0.05) of children with first-degree familial
atopy developed asthma.
Elevated levels of total IgE have been correlated with
the risk of developing asthma by Burrows [29] and
Wuthrich [30]. This also emerged from our study: 22.5%
of children with increased IgE developed asthma in com-
parison to 10.6% with normal IgE (Fisher's exact test; P <
0.005). These children appear to have a relative risk of
developing asthma that is twice that of those with normal
levels of IgE (RR = 2.12).
The aim of this work is to verify whether the refinement
of the allergic investigations (in 1989 the determination of
sIgE changed, passing from a semiquantitative method to
a quantitative method) had allowed us to identify more
quickly the risk factors of AD evolving into respiratory
allergic diseases and to improve the course of the disease.
In the literature there appears to be no reports focusing
on long-term studies of clinical and allergometric evalua-
tions observed during the course of AD with respect to its
evolution and association with allergic responses in
affected patients. The presence of an allergic sensitization
(foods and/or inhalnts) is an important risk factor for the
evolution into respiratory allergic disease [31]. Tables 1, 2
and 3 show that the atopic sensitization assessed both
through sIgE serum levels and SPT is significantly corre-
lated to the appearance of asthma. Moreover, the evalua-
tion of sIgE with the quantitative method allowed us to
verify that some positivities are particularly significant,
such as that linked to atopic sensitization for hen's egg
and cow's milk (unlike in our previous work [3]) with val-
ues of sIgE > 2 KU/L (Tab. 2 and 3). Our results are in
accordance with those of Nickel [12] where the sensitiza-
tion to hen's egg at one year of age seems to be predictive
Table 3: Persistence of AD and appearance of RC and/or asthma in relation to hen's egg sensitization assessed through 
sIgE (levels of IgE > 0.35 KU/L, between 0.35 and 2 KU/L and > 2 KU/L), and through SPT at first observation.
Variables Category N AD persistence RC appearance Asthma 
appearance
Hen's egg sensitization Absent 97 42 27 12
(specific IgE > 0.35 KU/L) 43,3%(33,4-53,2) 27%(18.9-36,8) 12,4%(5,8-18,9)
Present 79 42 21 18
53,2%(42,2-64,2) 26,6%(16,8-36,3) 22,8%(13,5-32,0)
Hen's egg sensitization Absent 145 68 43 25
(specific IgE 0,35-2 KU/L) 47%(38,8-55,0) 30%(32,2-37,1) 17%(11,1-23,4)
Present 31 16 5 5
52%(34,0-69,2) 16%(3,2-29,1) 13%(1,1-24,7)
Hen's egg sensitization Absent 128 58 32 17
(specific IgE > 2 KU/L) 58%(36.7-53.9) 25%(17.5-32.5) 13%(7.4-19.2)$
Present 48 26 16 13
54%(40.1-68.3) 33%(20.0-46.7) 27%(14.5-39.7)$
Hen's egg sensitization Absent 97 42 27 11
(PRICK) 43.3%(33.4-53.2) 27.8%(18.9-36.8) 11.3%(5.0-17.7)$
Present 79 42 21 19
53.2%(42.2-64.2) 26.6%(16.8-36.3) 24.1%(14.6-33.5)$
Confidence intervals 95% for each item.
Atopic Dermatitis (AD), Rhinoconjunctivitis (RC), Immunoglobulin E (IgE).
$ Fisher's exact test; P < 0.05
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Page 10 of 12of a sensitization to inhalant allergens in late infancy. This
is also confirmed by a literature [25,32]. The observation
of a relationship between sensitization to foods and inhal-
ants, and the subsequent appearance of asthma suggests
that this group of children is particularly at risk and could
be included in a program of preventive intervention.
One of the limitations of our study is the lack of some
demographic data of children, including immigration sta-
tus, parents' level of education, family income. These are
all factors that might influence the persistence or remis-
sion of atopic dermatitis. Another limitation is due to the
possible selection bias linked to disease severity: children
Figure 3 Persistence of AD in relation to the severity of the AD at first observation.
Table 4: Evolution of AD in 176 children: retrospective analysis aimed at identifying the associated risk factors linked to 
the appearance of RC and asthma, made through the evaluation of the odds correct ratio (OR) of models of logistic 
regression applied to the data.
Dependent 
variables
Covariate OR OR LCL 95% OR UCL 95% P
RC onset Asthma onset 2.764 1.108 6.896 0.029
Female 0.461 0.212 1.001 0.050
Asthma onset RC onset 2.616 1.034 6.617 0.042
Inhalant 
sensitization
4.219 1.191 14.948 0.026
Logistic regression applied to characterize risk factors or protective factors from asthma and RC.
Atopic dermatitis (AD); lower confidence limit (LCL); odds ratio (OR); rhinoconjunctivitis (RC); upper confidence limit (UCL).
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Page 11 of 12with more severe disease might have been more easily
contacted because of more recent routine follow-up vis-
its, as compared to children with less severe disease.
However, this possible bias might have influenced also
our previous study and should not affect the final result
and the comparison of the emerging data.
In conclusion, our work highlighted the importance of
the adoption of both a quantitative evaluation of sIgE and
improved clinical tools for the assessment of AD (SCO-
RAD index, environmental prevention, integrated man-
agement) in the routine clinical practice. Sensitization to
milk and hen's egg with values of sIgE > 2KU/L can be
included among the risk factors for the development of
asthma. Positivity to inhalants, on the other hand, is
already a risk factor at values > 0.35 KU/L at one year of
life. Although there appears to be a strong association
between AD and allergy, the natural course of the disease
seems poorly related to the allergic sensitization. How-
ever, given the decrease in the percentage of children
evolving toward respiratory allergic disease compared to
previous study [3], we stress the importance of early diag-
nosis, of therapeutic measures and of assiduous clinical
check-ups carried out by specialist centers. Finally, our
study has also highlighted the validity of the SPT in child-
hood as a means of early detection of subjects susceptible
to respiratory allergic diseases.
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